Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as art. Additionally we are shipping MMP14 Proteins (23) and MMP14 Kits (22) and many more products for this protein.
Showing 10 out of 244 products:
Human Polyclonal MMP14 Primary Antibody for FACS, IHC (p) - ABIN390138
Will, Hinzmann: cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. in European journal of biochemistry / FEBS 1995
Show all 4 references for ABIN390138
Human Polyclonal MMP14 Primary Antibody for ELISA, WB - ABIN1536142
Sato, Takino, Okada, Cao, Shinagawa, Yamamoto, Seiki: A matrix metalloproteinase expressed on the surface of invasive tumour cells. in Nature 1994
Show all 2 references for ABIN1536142
Human Polyclonal MMP14 Primary Antibody for EIA, IHC (p) - ABIN358687
Takino, Sato, Yamamoto, Seiki: Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-terminal transmembrane domain. in Gene 1995
Show all 2 references for ABIN358687
Human Monoclonal MMP14 Primary Antibody for IHC (fro), IHC (p) - ABIN567585
Cupler, Danon, Jay, Hench, Ropka, Dalakas: Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations. in Acta neuropathologica 1995
Human Polyclonal MMP14 Primary Antibody for WB - ABIN1881546
Sakr, Takino, Domoto, Nakano, Wong, Sasaki, Nakanuma, Sato: GI24 enhances tumor invasiveness by regulating cell surface membrane-type 1 matrix metalloproteinase. in Cancer science 2010
The results suggest that MT1-MMP promotes esophageal squamous cell carcinoma invasion and metastasis.
Report design of PEGylated peptide probes conjugated with (18)F-labeled BODIPY to be used as a hybrid PET/optical imaging agent and for non-invasive monitoring of MT1-MMP activity in cancers.
Rab8 (show RAB8A Antibodies) can induce Rac1- and Tiam1 (show TIAM1 Antibodies)-dependent cortical actin polymerization and focal adhesion disassembly through the proteases MT1-MMP and calpain, and Rho-GTPase (show RACGAP1 Antibodies)-dependent mechanisms
Downregulation of miR (show MLXIP Antibodies)-193a-3p promoted loss of type II collagen (show COL2A1 Antibodies) by directly targeting MMP14 in IDD (show COL9A3 Antibodies). miR (show MLXIP Antibodies)-193a-3p inhibited IDD (show COL9A3 Antibodies) in vitro and in vivo. miR (show MLXIP Antibodies)-193a-3p may be a promising candidate for prevention of degenerative disc disease.
These results suggest that KLF6 (show KLF6 Antibodies) regulates MMP14 transcription and is a critical player of the gene expression network triggered during endothelial repair.
In summary, clinical and cell-based experiments suggested that physical interaction between MT1-MMP and ADI1 (show ADI1 Antibodies) led to suppression of hepatitis C virus infection. This inhibitory effect could be reversed by ADI1 (show ADI1 Antibodies) overexpression.
Matrix metalloproteinase 14 was highly expressed in uterine leiomyoma and correlated with myostatin (show MSTN Antibodies) and activin A (show INHBA Antibodies) mRNA expression. Moreover, MMP14 and myostatin (show MSTN Antibodies) mRNA expression correlated significantly and directly with the intensity of dysmenorrhea.
Hic-5 (show TGFB1I1 Antibodies) appears to enhance complex formation between MT1-MMP and FAK (show PTK2 Antibodies) in activated endothelial cells, which likely coordinates matrix proteolysis and cell motility.
Increased MMP14 expression is associated with malignant phenotype of cervical cancer.
Silencing KIF1B (show KIF1B Antibodies) inhibited expression of membranal MT1-MMP in glioma cells; however, the amount of MT1-MMP in the whole cell lysate was not affected.
MT1-MMP directly cleaves LYVE-1 (show LYVE1 Antibodies) on lymphatic endothelial cells to inhibit LYVE-1 (show LYVE1 Antibodies)-mediated lymphangiogenic responses and restrains the production of VEGF-C (show VEGFC Antibodies).
The authors propose a model for cell-regulated collagen fibril assembly during tendon development in which MMP14 cleaves a molecular bridge tethering collagen fibrils to the plasma membrane of fibripositors.
We demonstrate that MMP-14-mediated signaling in fetal hepatic progenitor cells promotes biliary luminal formation around the portal vein and negatively controls the maturation of hepatocytes.
Results show a reciprocal association between levels of heparanase (show HPSE Antibodies) and MMP14, a membrane-bound MMP, shedding light on how branching occurs within developing mammary glands.
MT1-MMP proteolytic activity is required for maintaining cell integrity, loss of MT1-MMP causes cell senescence and nuclear defects.
of the transcripts of tissue inhibitors of matrix metalloproteinases (TIMPs) showed that expression of both TIMP1 (show TIMP1 Antibodies) and TIMP2 (show TIMP2 Antibodies) correlates negatively with the invasive potential of cells.
Angiotensin II suppresses RECK (show RECK Antibodies), but induces matrix metalloproteinases both in vivo and in vitro.
Active MT1-MMP promotes Notch1 (show NOTCH1 Antibodies) cleavage independently of ADAM10 (show ADAM10 Antibodies) or -17.
LV mass was similar among WT, MT1-MMP overexpression, and MT1-MMP reduced expression after PO, significant differences in LV function.
In the kidneys of Sirt1 (show SIRT1 Antibodies)(endo-/-) mice, impaired angiogenesis, reduced matrilytic activity, and retention of the profibrotic cleavage substrates tissue transglutaminase (show TGM2 Antibodies) and endoglin (show ENG Antibodies) accompanied MMP-14 suppression.
Data indicate the involvement of PKC-alpha (show PKCa Antibodies) in proMMP-2 activation and inhibition of TIMP-2 (show TIMP2 Antibodies) expression by NF-kappaB (show NFKB1 Antibodies)-MT1-MMP-dependent and -independent pathway.
Data suggest that EMMPRIN derived from endometrial epithelial cells regulates expression of matrix metalloproteinases (MMP-2 (show MMP2 Antibodies); MMP-14) in endometrial stromal cells; expression of stromal MMPs is significantly higher in coculture with epithelial cells.
MMP-14, MMP-2 (show MMP2 Antibodies) and TIMP-2 (show TIMP2 Antibodies) are co-localized in the fetal compartment and therefore could influence the timely release of fetal membranes in cattle.
Results describe distinct changes in expression of MMP2 (show MMP2 Antibodies), MMP14, and the metallopeptidase (show ECEL1 Antibodies) inhibitor TIMP2 (show TIMP2 Antibodies) between different phases of the estrous cycle indicating an endocrine regulation.
EMMPRIN from the luminal epithelium may regulate the expression of stromal MMP-2 (show MMP2 Antibodies) and MMP-14 suggesting a role in adhesion and fusion of embryo to luminal epithelium.
MT1-MMP seems to act by inducing tissue remodeling in cartilage
sphingosine 1-phosphate is the predominant serum factor essential for MT1-MMP-dependent migration and morphogenic differentiation of vascular endothelial cells
MT1-MMP plays a crucial role in RAGE (show AGER Antibodies)-activated NADPH oxidase (show NOX1 Antibodies)-dependent signaling pathways.
MMP-1 (show MMP1 Antibodies) was involved in osteoarthritis development in rabbit ACLT model and the amount of its expression was related with the degree of cartilage degradation.
Modulation of MT1-MMP activity and microRNA-133a exportation into the myocardial interstitium occurred in the setting of acute myocardial ischemia-reperfusion.
A heterogeneous response in MT1-MMP activity likely contributes to regional dysfunction with ischemia-reperfusion. Subsequent I/R activates a proteolytic cascade within the MI region, contributing to continued adverse remodeling.
PI3K-dependent regulation of MT1-MMP protein synthesis and subsequent activation of latent MMP-2 (show MMP2 Antibodies) as critical events in neointimal hyperplasia after vascular injury.
Induction of endogenous MMP-14 gene and coexpression of SAF-1 (show MAZ Antibodies) & MMP-14 in the macrophages present in the atherosclerotic plaque implicate SAF-1 (show MAZ Antibodies) as a key regulator of MMP-14 gene induction in macrophage cells.
In an isolated left ventricular myocyte ischemia/reperfusion model, hypoxia induced a >70% increase in MT1-MMP abundance in myocytes. Confocal microscopy revealed MT1-MMP internalization during this time & reemergence to the membrane with reperfusion.
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily\; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion.
matric metalloproteinase 14
, matrix metalloproteinase-14
, membrane type 1 metalloprotease
, membrane-type-1 matrix metalloproteinase
, MT-MMP 1
, Membrane type 1-MMP
, matrix metalloproteinase 14 (membrane-inserted)
, membrane-type matrix metalloproteinase 1
, type 1 matrix metalloprotease 14
, matrix metalloproteinase 14 membrane-inserted
, matrix metalloproteinase 14, membrane-inserted
, membrane type 1-matrix metalloproteinase
, matrix metalloproteinase 14 preproprotein
, matrix metallopeptidase 1 (interstitial collagenase)
, matrix metalloproteinase 14
, membrane type 1 metalloproteinase
, membrane-type 1 matrix metalloproteinase
, membrane type-1 metalloproteinase